CrestPoint Capital Management’s Medtronic MDT Stock Holding History

CrestPoint Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,800	Closed	-$207K	–	224
2015 Q2	$207K	Sell	2,800 -100	-3%	-$7.64K	0.11%	214
2015 Q1	$226K	Sell	2,900 -100	-3%	-$7.58K	0.12%	209
2014 Q4	$217K	Buy	+3,000	New	+$208K	0.12%	212
2014 Q3	–	Sell	-3,400	Closed	-$217K	–	216
2014 Q2	$217K	Sell	3,400 -200	-6%	-$12.2K	0.13%	208
2014 Q1	$222K	Hold	3,600	–	–	0.14%	200
2013 Q4	$207K	Buy	+3,600	New	+$204K	0.14%	199

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

CrestPoint Capital Management's MDT Position: Q3 2015 in Review

CrestPoint Capital Management sold out of Medtronic (MDT) in Q3 2015, closing a stake of 2,800 shares — an estimated $207K sold.

CrestPoint Capital Management first reported a position in MDT in Q4 2013 and held it in 6 quarters. The position peaked at $226K in Q1 2015. 1,209 funds tracked by Wall St. Rank hold MDT as of Q3 2015.

CrestPoint Capital Management reported no remaining Medtronic position as of Q3 2015 after selling out during the quarter.
CrestPoint Capital Management sold 2,800 Medtronic shares in Q3 2015, an estimated $207K.
CrestPoint Capital Management first reported a position in Medtronic in Q4 2013 and held it in 6 quarters.
CrestPoint Capital Management's Medtronic position peaked at $226K in Q1 2015.
1,209 funds tracked by Wall St. Rank held Medtronic as of Q3 2015.

Based on CrestPoint Capital Management's 13F filing for Q3 2015, filed 15 Oct 2015.